9 April 2025 – Nottingham, UK – Upperton Pharma Solutions, a leading UK-based contract development and manufacturing...
9 April 2025 – Nottingham, UK – Upperton Pharma Solutions, a leading UK-based contract development and manufacturing...
2 April 2025 – Clearwater, Florida, US – Bend Bioscience, a leading innovation, science, and pharmaceutical services...
Cool storage volume to be doubled by 2028 Third expansion stage of Vetter’s Center for Visual Inspection and Logistics...
18 February 2025 – Columbus, OH, US – Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy...
Gaelic Laboratories, a European CMO based in Ireland, has established a subsidiary in the UAE, enabling access to the...
Leading CDMO performing sterile drug manufacturing, lyophilization, testing/QA and packaging operations for...
Aseptic Fill-Finish CDMO Ajinomoto Althea Acquisition creates a world-class large-scale manufacturing hub in San Diego region with state-of-the-art aseptic facilities for prefilled syringes, cartridges and high potent formulations such as ADCs, complementing existing...
Philadelphia, PA – PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is acquiring an entire equity stake in Ajinomoto Althea, Inc. (“Althea”), a US-based sterile...
Giesen, Germany. 23rd April 2025: With operational costs rising and production line efficiency under pressure, manufacturers need to be confident that any new equipment investment will deliver value. That’s why Mettler-Toledo Product Inspection is spotlighting its...
His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, has witnessed the inauguration of a regional vaccine distribution hub in Abu Dhabi during Abu Dhabi Global Health Week (ADGHW) 2025....
CLEVELAND, US - 21 June 2023 - The Lubrizol Corporation announces the licensing of its novel excipient polymer technology, Apisolex excipient, to Welton Pharma (Welton). The license allows Welton to use the Apisolex excipient worldwide to develop and commercialise a...